Posted on

Hunton Strengthens Public Affairs Consultancy with Addition of Jason Powell as Director of Government Affairs in Richmond

Richmond, VA, July 20, 2026 (GLOBE NEWSWIRE) — Hunton Andrews Kurth LLP is pleased to welcome Jason W. Powell, former senior advisor to the Virginia Secretary of Finance, as the firm’s director of government affairs in the global economic development, commerce and government relations group, the firm’s full-service public affairs consultancy.

By sf-admin
Posted on

The City of Houston selects CDM Smith for engineering design services to expand the East Water Purification Plant

The city of Houston, Texas selected CDM Smith to provide design services for Project 1 of the East Water Purification Plant (EWPP) Enhancement project, estimated at $2.2 billion in construction. 

The city of Houston, Texas selected CDM Smith to provide design services for Project 1 of the East Water Purification Plant (EWPP) Enhancement project, estimated at $2.2 billion in construction.

By sf-admin
Posted on

NEOMED partners with Mercy Health in Cincinnati, Youngstown and Lorain to expand clinical training, strengthen Ohio’s physician workforce

Cleveland, Ohio, July 20, 2026 (GLOBE NEWSWIRE) — Cincinnati-based Mercy Health and Northeast Ohio Medical University (NEOMED) formed a strategic partnership aimed at expanding workforce development initiatives and building a strong pipeline of physicians to serve communities statewide. Mercy Health operates the largest number of hospitals in Ohio.  

By sf-admin
Posted on

Malignant Pleural Effusion Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2026–2036) | DelveInsight

The malignant pleural effusion market is expected to witness steady growth over the coming years, driven by the increasing incidence of metastatic cancers, particularly lung, breast, and ovarian cancers. Rising awareness, improved diagnostic techniques, and advancements in minimally invasive drainage and pleural management procedures are contributing to market expansion. Additionally, the launch of emerging therapies such as PTS500 (Gongwing Biopharm), M701 (Wuhan YZY Biopharma), RSO-021 (RS Oncology), and others will further propel the market growth. 

The malignant pleural effusion market is expected to witness steady growth over the coming years, driven by the increasing incidence of metastatic cancers, particularly lung, breast, and ovarian cancers. Rising awareness, improved diagnostic techniques, and advancements in minimally invasive drainage and pleural management procedures are contributing to market expansion. Additionally, the launch of emerging therapies such as PTS500 (Gongwing Biopharm), M701 (Wuhan YZY Biopharma), RSO-021 (RS Oncology), and others will further propel the market growth.

By sf-admin